{
  "name" : "dacemirror.sci-hub.se_journal-article_7615dd607d7622f08445a184af9cca0b_prajapati2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "pH-Responsive Nano-Self-Assemblies of the Anticancer Drug 2-Hydroxyoleic Acid",
    "authors" : [ "Rama Prajapati", "Mark Gontsarik", "Anan Yaghmur", "Stefan Salentinig" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "■ INTRODUCTION Cancer is one of the major public health problems worldwide.1−3 Along with the current cancer therapies, including surgical intervention and radiation therapy, chemotherapy is characterized as the least invasive cancer treatment approach with a clinical success in tumor shrinking and cancer relapse reduction.4−6 However, chemotherapy is often associated with side-effects caused by the off-site toxicity due to the lack of drug specificity.5 Hence, the design of novel and more efficient cancer nanomedicines that can selectively target the tumor sites, avoiding off-target side-effects, may improve current therapies and also patients’ quality of life.5,7−10 Among different suggested nanomedicines, pH-triggered chemotherapeutic delivery systems may be of interest in cancer treatment, as the extracellular microenvironment of tumor cells with pH of around 5.5−6.5 is more acidic than that of healthy cells with pH of 7.4.10−12 The occurrence of such acidic local tumor microenvironment is attributed to an increased glycolysis rate, a higher production level of lactic acid, and an insufficient vasculature for the removal of acidic byproducts.11,13−18\nThis study describes the formation and characterization of pH-responsive self-assembled nanocarriers based on glycerol\nmonooleate (GMO), and the anticancer drug 2-hydroxyoleic acid (2OHOA). The molecular structures of both lipids are presented in Figure 1. The poorly water-soluble anticancer drug 2OHOA is a derivative of oleic acid (OA) with an additional hydroxyl group on the α-carbon of the fatty acid backbone.19 It is a potent anticancer agent that induces cell\nReceived: March 21, 2019 Revised: May 17, 2019 Published: May 23, 2019\n© 2019 American Chemical Society 7954 DOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\nD ow\nnl oa\nde d\nvi a\nU N\nIV O\nF SO\nU T\nH E\nR N\nI N\nD IA\nN A\no n\nJu ly\n1 8,\n2 01\n9 at\n0 3:\n21 :5\n9 (U\nT C ). Se e ht tp s: //p ub s. ac s. or g/ sh ar in gg ui de lin es f or o pt io ns o n ho w to le gi tim at el y sh ar e pu bl is he d\ncycle arrest and apoptosis, cellular differentiation, and autophagy in a wide range of human cancer cells, including leukemia, glioma, lung, colon, and breast cancer cells.19−27\nGMO-based nanocarriers have been previously used for enhancing the solubilization of poorly water-soluble therapeutic agents.28−35 Among these nanocarriers, dispersions of inverse bicontinuous cubic, hexagonal, and micellar cubic structures (cubosomes, hexosomes, and micellar cubosomes, respectively), emulsified microemulsions, vesicles, and sponge phases are gaining increasing attention for their drug delivery applications. The biological relevance and the relatively large extent of the internal lipid−water interfacial area render these colloidal nanosystems attractive for delivering hydrophilic, hydrophobic, and amphiphilic drugs and peptide molecules.36−48 For targeted delivery applications, they can be surface nanoengineered to respond to an external stimulus, such as pH, for triggering the release of therapeutic molecules or enhancing the interactions with cells on demand, owing to structural alterations in these nanocarriers.33,49−55 Despite the attractiveness of cubosomes, hexosomes, and related nonlamellar liquid crystalline nanoparticles in the development of injectable drug nanocarriers, there is still to date no FDAapproved formulation based on these nanostructured emulsions.56,57 Nevertheless, recent in vivo studies showed that these nanoparticles are promising candidates in the development of nanocarriers for anticancer drug delivery.58,59\nThe major goal of this study is to investigate the composition and pH dependence of 2OHOA/GMO nanoself-assemblies and gain further insight into their pH-triggered structural, morphological, and size alterations by using synchrotron small-angle X-ray scattering (SAXS), cryogenic transmission electron microscopy (cryo-TEM), and ζ-potential measurements. An improved understanding of the structural mechanism involved in these pH-triggered transitions is an important keystone toward the development of pH-responsive anticancer nanomedicines. Based on the presented experimental findings, the pH-induced phase transformations in the interiors of 2OHOA/GMO nanoparticles are most likely attributed to the protonation/deprotonation of the carboxylic group of 2OHOA at the lipid−water interface. The presented results shed light on the molecular interactions during the selfassembly of a cell membrane active anticancer agent with a biologically relevant lipid in excess buffer and could potentially be applied for the future design of pH-guided nanocarriers for tumor-targeted delivery of anticancer drugs.\n■ EXPERIMENTAL SECTION Preparation of 2OHOA/GMO Nanodispersions. Sodium salt of 2-hydroxyoleic acid (2OHOA; Avanti polar lipids, Alabama, U.S.A.) and glycerol monooleate (GMO; ≥90% purity, Riken Vitamin co., Ltd. company, Japan) were weighed out in glass vials at 3/7 and 1/1 2OHOA/GMO mass ratios and dispersed in 149 mM Dulbecco’s Phosphate-buffered saline (PBS) at pH 7.4 (Sigma-Aldrich, Poole, UK), containing 2 mg/mL Pluronic F127 (gift from BASF SE, Ludwigshafen, Germany), to achieve a total lipid concentration of 20 mg/mL. These raw lipid emulsions were then homogenized by means of ultrasonication (Ultrasonic Processor Qsonica 500, Qsonica LLC, Newtown, CT, U.S.A.) for 4 min in pulse mode (3 s pulse, 5 s break) at 27% of its maximum power (500 W). The pH of the prepared nanodispersions was then adjusted with 1 M NaOH (≥99% purity, Carl Roth GmbH, Karlsruhe, Germany) or 1 M HCl prepared from 37% HCl stock solution (ACS reagent grade, Sigma-Alrdich, Buchs, Switzerland) and allowed to equilibrate at 25 °C for at least 1 h before carrying out the planned experiments. In this study, the pH of the\ncontinuous aqueous medium of the dispersion with 1/1 2OHOA/ GMO mass ratio was first gradually decreased from 7.4 to 2.0 and then increased back to 5.0, while taking out samples at different selected pH points for SAXS structural characterization. This pH cycle was applied to study whether the structural alterations associated with changing pH can be reversed. Double distilled water was used for the preparation of all samples. All ingredients were used without further purification.\nSynchrotron Small-Angle X-ray Scattering (SAXS). SAXS patterns were recorded at the Austrian SAXS beamline at the synchrotron light source ELETTRA (Trieste, Italy). An X-ray beam with a wavelength of 1.54 Å (8 keV) was used, with a sample-todetector distance of 1314 mm, covering a q-range from about 0.18 to 5.00 nm−1, where q is the length of the scattering vector, defined by q = 4π/λ sin(θ/2), λ being the wavelength, and θ the scattering angle. The samples were sealed in thin-walled quartz capillaries and five frames with an exposure time of 20 s per frame were collected and averaged at room temperature. The 2D SAXS patterns were acquired using a Pilatus3 1 M detector (Dectris Ltd., Baden, Switzerland; active area 169 × 179 mm2 with a pixel size of 172 × 172 μm2), integrated into one-dimensional (1-D) scattering function I(q) using Fit2D60 (European Synchrotron Radiation Facility, Grenoble, France) and then analyzed with IGOR pro (Wavemetrics, Inc., Lake Oswego, U.S.A.). The scattering curves were plotted as a function of intensity, I(q), averaged over the five repeated exposures versus q. The scattering from PBS was subtracted as background from all measurements before further data analysis. The calculation of the lattice parameters of the corresponding lyotropic nonlamellar liquid crystalline phases is described in SI (eqs S2−S4).\nCryogenic-Transmission Electron Microscopy (cryo-TEM). The morphological characterization of F127-stabilized 2OHOA/ GMO nanoparticles was done in their vitrified states by cryo-TEM imaging. Briefly, lacey carbon 300 mesh copper grid (Ted Pella Inc., CA, U.S.A.) enforced by a silicon monoxide coating was subjected to glow discharge treatment and treated with 3 μL of the sample. The excess sample on the grid was then blotted with filter paper at a blotting time of 3.5 s, a blotting force 0, temperature 25 °C, and 100% humidity (FEI Vitrobot IV, Holland) and was rapidly plunged into liquid nitrogen-cooled ethane close to its melting point (−174 °C). A Gatan 626 cryo-holder (Gatan, U.K.) was used to transfer the plunged grid with the samples in a frozen glassy state into the Tecnai G2 20 transmission electron microscope (FEI, Holland). The images were digitally recorded at a voltage of 200 kV, under low-dose conditions (∼5 e/Å2s), and at a magnification of ×29 000.\nζ-Potential Measurements. The ζ-potential of the 2OHOA/ GMO nanodispersions was measured at different pH using Zetasizer Nano ZS equipped with a 633 nm laser (Malvern Instruments, Worcestershire, U.K.). Prior to measurements at 25 °C and 173° scattering angle, the samples were diluted 1/100 in PBS and their pH was readjusted. ζ-potential was calculated by Zetasizer Software 7.11 (Malvern Instruments) using Smoluchowski equation:61\nμ ε ε ζ\nη =e\nr 0\n(1)\nwhere μe is the electrophoretic mobility, εr is the dielectric constant of water, εo is the permittivity of vacuum, and η is the viscosity of the solvent (water). The measurements were done in triplicate and averaged. Estimations of 2OHOA’s pKa\napp from the ζ-potential values are described in the SI.\n■ RESULTS AND DISCUSSION The GMO dispersed in water forms cubosomes with an internal bicontinuous cubic phase of the Pn3m or Im3m type symmetry depending on the F127 stabilizer concentration.62,63 The integration of the anticancer drug 2OHOA into this dispersion led to composition- and pH-dependent nanostructural transformations in the nanocarriers. Figure 2 demonstrates the pH-dependent self-assembly of the binary\nDOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\n7955\n2OHOA/GMO self-assemblies in excess buffer at a mass ratio of 1/1. The appearance of three dominating Bragg reflections in the SAXS curves at q values of 1.26, 2.17, and 2.51 nm−1, corresponding to a peak spacing-ratio of 1:√3:√4, indicate the formation of hexosomes with an inverse hexagonal (H2) phase at pH 2.0. The corresponding lattice parameter, aH2, is 5.8 nm. Additional weak reflections, occurring most prominently around q ≈ 1.1 nm−1, indicate a coexisting bicontinuous cubic structure with Pn3m symmetry having a lattice parameter, aPn3m, of 8.0 nm. These results demonstrate that the 2OHOA mostly integrates into the hydrophobic domains of the self-assembled nanostructure at pH 2.0. This integration increases the apparent volume of the hydrophobic domains, which ultimately leads to the nanostructural transition from cubosomes to hexosomes. This observation agrees with theoretical considerations from the critical packing parameter model (see SI). The trend is also consistent with 2OHOA-induced lamellar-nonlamellar structural transitions in dielaidoylphosphatidylethanolamine dispersion.24,64\nUpon increasing the pH from 2.0 to 3.0, the Bragg peaks of the H2 phase shifted to lower q values, corresponding to an increase in aH2 to 5.9 nm (Figure 2). In addition to the characteristic reflections of the H2 phase, additional Bragg peaks with peak-ratios of √2:√3:√4:√6:√8:√9 were detected. These peaks could be indexed as the (110), (111), (200), (211), (220), and (221) reflection of the bicontinuous Pn3m-type cubic structure with aPn3m = 8.3 nm. In this phase assignment, it should be noted that the characteristic reflection (220) of the cubic Pn3m phase at pH 2.0 and 3.0 appears to overlap with the characteristic reflection (11) of the coexisting H2 phase. A single peak around q ≈ 0.8 nm−1 was also observed, likely resulting from traces of a coexisting Im3m-type bicontinuous cubic structure. The identification of this coexisting Im3m structure was based on its gradual evolvement with a further increase in pH. At pH 3.5, the Bragg reflections of the H2 phase diminished and peaks indicating a coexistence of Pn3m and Im3m phase were observed. The corresponding lattice parameters for the biphasic Pn3m/Im3m feature were 9.1 and 12.0 nm, respectively. Further increase in pH to 4.0 caused a shift in the peak positions of the Pn3m and Im3m phases to lower q values, resulting in an increase in aPn3m to 9.9 nm and aIm3m to 12.9 nm. At pH 4.5, the lattice parameters of Pn3m and Im3m increased to 12.3 and 15.3 nm, respectively. The ratio of aIm3m/aPn3m was calculated and found to be 1.32, 1.30, and 1.24 at pH 3.5, 4.0, and 4.5. This ratio is consistent with the reported theoretical Bonnet ratio of 1.279 for these structures36,65 (Table S1). At pH 5.0 and 6.0, two Bragg peaks at q values of about 1.56 and 3.12 nm−1 were observed, showing the formation of multilamellar vesicles (MLVs) with an interlamellar d-spacing of about 4.0 nm, in agreement with the previously reported bilayer dimensions in GMO-based selfassemblies.66,67 At pH 7.4, the diffuse-dominating scattering patterns indicated the formation of unilamellar vesicles (ULVs). The additional broad correlation peaks in the low-q region of the SAXS curves at pH 6.0 and 7.4, with maxima around q ≈ 0.45 and 0.90 nm−1 are most likely attributed to weak bilayer correlations in a coexisting population of swollen bi- or multilamellar vesicles with an estimated d of around ∼14 nm. The formation of highly swollen lamellar structures with similar bilayer-to-bilayer spacing and low repeat numbers was also previously reported for nano-self-assemblies of GMO with the anionic phospholipid dioleoyl-phosphatidylglycerol.67\nTo evaluate the potential to reverse the colloidal transformations in this system, the pH in the sample at 1/1 2OHOA/GMO mass ratio was decreased from pH 7.4, where vesicles were the dominating species, to pH 2.0 where cubosomes and hexosomes dominated (Figure 2). The following pH increase to 5.0 in this sample led to the reformation of vesicles, demonstrating the pH-induced transformations from nonlamellar structures to vesicles and back upon circulating the pH of the continuous water phase. The pH-triggered swelling of nonlamellar liquid crystalline structures and the gradual nonlamellar-lamellar transitions have been previously reported for self-assemblies containing the analogue OA50,52,69,70 and other fatty acids.49,71\nThe cryo-TEM images of the 2OHOA/GMO nano-selfassemblies at 1/1 mass ratio confirmed the pH-triggered nanostructural transitions observed by SAXS. Hexosomes were observed at pH 2.0, and internally structured nanoparticles coexisting with vesicles were found at pH 4.0 (Figure 3A,B). At pH 6.0, the cryo-TEM image (Figure 3C) indicated the\nDOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\n7956\npresence of MLVs coexisting with smaller ULVs. The image at pH 7.4 (Figure 3D) was dominated by ULVs mostly below 100 nm in diameter, coexisting with bilamellar vesicles. The bilayer-to-bilayer distance of around 10 nm in the cryo-TEM of multilamellar vesicles at pH 7.4 (Figure 3D) correlates reasonably well with the estimated interlamellar distance from SAXS (Figure 2).\nFigure 4 shows the SAXS patterns for the 2OHOA/GMO nano-self-assemblies at a 2OHOA/GMO mass ratio of 3/7, in the pH range of 2.0−7.4. At pH 2.0, the SAXS curve shows the characteristic peak-spacing of the Pn3m type cubic phase with aPn3m of 8.39 nm. Hence, compared to the dispersion that was prepared at a mass ratio of 1/1, the 2OHOA content in this sample is insufficient to induce a Pn3m-to-H2 phase transition even at pH 2.0. On increasing pH to 3.0 and 3.5, the calculated lattice parameter of the cubic Pn3m phase increased to 8.6 and 9.3 nm, respectively. However, three additional Bragg peaks at q values of 0.72, 1.02, and 1.25 nm−1 with peak spacing-ratio of √2:√4:√6 were observed at pH 3.5, which can be attributed to a coexisting Im3m phase with aIm3m of 12.3 nm. The calculated ratio between the lattice parameters of Im3m and Pn3m phases was 1.33 and fairly consistent with the theoretical Bonnet ratio (Table S1). The SAXS curve at pH 4.0 was dominated by the Im3m phase with aIm3m of about 14.6 nm, as the three Im3m peaks were shifted to lower q values. Further increase in pH to 4.5−7.4 led to the loss of the highly ordered nonlamellar structures and the appearance of diffusive SAXS curves, indicating a transformation to vesicles. The correlation peaks observed in the low-q region of curves at pH 6.0 and 7.4, with their maxima around 0.48 and 0.96 nm−1, may correspond\nto the weak bilayer correlations of a coexisting population of highly swollen MLVs with an estimated d of around 13 nm in agreement with the discussions above. The structural transformations of the 2OHOA/GMO nanoself-assemblies upon increasing pH from 2.0 to 7.4 are attributed to the charge repulsions between the gradually deprotonating carboxylic groups of 2OHOA embedded at the lipid−water interface. Such repulsions would increase the effective headgroup area of the embedded 2OHOA molecules at the lipid−water interface, modifying its spontaneous curvature. Figure 5 summarizes the pH-induced phase transitions and changes in the lattice parameters for all phases detected on increasing pH from 2.0 to 4.5 for both 2OHOA/ GMO samples prepared at mass ratios of 3/7 and 1/1. The cubic Im3m phases in both 2OHOA/GMO dispersions summarized in Table S1 have smaller lattice parameters at pH 3.0 and 3.5 than pristine GMO cubosomes with aIm3m = 13.1 nm around the same pH (see Figure S1). This is consistent with the integration of 2OHOA into the hydrophobic domains of the structure at this pH value. On the other hand, upon reaching pH 4.0 and 4.5 in dispersions with 2OHOA/GMO mass ratios of 3/7 and 1/1, respectively, the aIm3m was found to be greater than that of GMO cubosomes in\narrows) with a bilayer-to-bilayer distance of around ∼10 nm (D). Figure 4. SAXS patterns of the F127-stabilized nanoself-assemblies\nprepared at 2OHOA/GMO mass ratio of 3/7 and pH in the range of 2.0−7.4. The Bragg peaks of the cubic Pn3m and Im3m phases and their corresponding Miller indices are indicated with red and black arrows, respectively. Low intensity peaks potentially from a coexisting Im3m phase are marked with black asterisks at pH of 2.0 and 3.0. Broad correlation peaks, most likely corresponding to the weak bilayer correlations in coexisting swollen MLVs, are marked with green asterisks at pH 6.0 and 7.4.\nDOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\n7957\nabsence of 2OHOA (Figure S1). The later dispersion, measured as control, showed only a slight structural alteration in response to pH change between 3.0 and 7.0. The increase in aIm3m from 13.1 nm at pH 3.0 to 13.5 nm at pH 7.0 may be attributed to the potential presence of trace concentrations of OA as a hydrolysis product in the sample.68 However, this change in lattice parameter in the 2OHOA free cubosomes is insignificant compared to that in the 2OHOA/GMO system reported above. The larger pH-induced increase in the lattice parameters of the internal liquid crystalline phases of the 2OHOA/GMO nanocarriers at pH 4.0−4.5, as compared to that at pH 3.0−3.5, reflected a higher degree of 2OHOA deprotonation and indicated the closer proximity to the apparent pKa (pKa\napp) of the embedded 2OHOA (Table S1). Upon increasing the pH to >5.0, the 2OHOA/GMO cubosomes eventually transformed into vesicles. The pH effect on the ζ-potential of 2OHOA/GMO nanoself-assemblies is demonstrated in Figure 6. At pH 2.0, the measurements for the dispersions with 1/1 and 3/7 2OHOA/ GMO mass ratios indicated the occurrence of rather neutral surfaces with ζ-potential values of −0.4 ± 0.7 and −3.8 ± 2.9 mV, respectively. The ζ-potential of these dispersions was observed to gradually decrease upon increasing pH, with the largest drop in ζ-potential occurring around pH 6.0, and reaching −30.9 ± 4.8 and −29.1 ± 3.5 mV at pH 9.0 for the samples with 1/1 and 3/7 2OHOA/GMO mass ratios, respectively. This decrease in ζ-potential is mostly caused by the deprotonation of 2OHOA, and correlated well with the discussed nanostructural transitions observed by SAXS and cryo-TEM. For the system at 2OHOA/GMO mass ratio of 1/1, the decrease in the ζ-potential from −5.8 ± 2.8 to −31.3 ± 1.7 mV on increasing pH from 5.0 to pH 7.5 could be associated with an increase in the electrostatic repulsions between the negatively charged 2OHOA/GMO bilayers in the MLVs. This charge repulsion between bilayer sheets could then induce the formation of the swollen MLVs with bilayer−\nbilayer distances above 10 nm at pH 6.0 and 7.4, as reported above. The pKa\napp values of 2OHOA in the nano-self-assemblies at 2OHOA/GMO mass ratios of 1/1 and 3/7 were calculated from the pH-dependent ζ-potential values (see Figure 6 and SI). The resulting pKa\napp values are 6.1 ± 0.1 and 5.7 ± 0.2, respectively. These pKa\napp values are slightly larger than the previously reported pKa\napp of 5.4 for 2OHOA in Triton X-100 micelles.64 This may be caused by the different 2OHOA content in the 2OHOA/GMO nano-self-assemblies (2OHOA/lipid mass ratios of 1/1 and 3/7) as compared to a mass ratio 1/9 in 2OHOA/Triton X-100 micelles. The higher concentration of ionizable carboxylic groups on the oil− water interface increases the negative surface-charge density, which could enhance the accumulation of protons, leading to an increase in pKa app.52,72 The results suggest that the pKa app of 2OHOA in the designed 2OHOA/GMO nanocarriers may be controlled through changes in the lipid composition. This could potentially be used to tune the phase boundaries of these self-assemblies to desired pH ranges for specific delivery applications. The detected pH-triggered structural transformations in this study can be of interest in the development of 2OHOA/GMO nanocarriers for tumor-targeted delivery applications. In the investigated nanocarriers, the major changes in the protonation state of 2OHOA occurred within the typical pH range of the extracellular tumor environment of pH 5.5−6.5.11,12 The modifications of the 2OHOA/GMO ratio in these nanocarriers was further found to modulate the pKa\napp of 2OHOA. Thus, the nanocarriers could be fine-tuned to obtain pH-triggered phase transitions at specific pH values by optimizing the lipid composition. Additionally, the introduction of hydrophobic additives, such as vitamin E or triglycerides, could increase the hydrophobic tail volume.73−78 This could also shift the phase boundaries between cubosomes and vesicles to higher pH values, even close to the physiological pH of 7.4. The reported pH-triggered nanostructural transformations could also trigger\nDOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\n7958\nspecific interactions of the nanocarriers with the cells, similar to previous observations on antimicrobial peptide nanocarriers.70 This would improve the targeted delivery of this anticancer agent and may focus its exposure to the acidic tumor microenvironment, minimizing off-target side-effects. Further in vitro and in vivo studies are required to determine the practical application of these nano-self-assemblies in cancer therapy.\n■ CONCLUSIONS The design and characterization of pH-responsive nanocarriers based on mixtures of 2OHOA with GMO are presented. In a concentration and pH dependent manner, 2OHOA was found to actively participate and modulate the structural features of GMO dispersion. The protonation state of the embedded 2OHOA at the lipid−water interfacial area dictated the structural and morphological characteristics of 2OHOA/ GMO nanocarriers. At pH <4.0, the mostly protonated 2OHOA integrated into the hydrophobic domains of the cubosomes, shrinking their internal channel dimensions and promoting the formation of the H2 phase. However, at pH ≥4.0, the gradual deprotonation of the 2OHOA molecules on increasing pH resulted in electrostatic repulsions among its deprotonated carboxyl-headgroups at the lipid−water interface. This caused the swelling of the cubic Pn3m and Im3m phases and eventually, at pH ≥4.5 the colloidal transformation from cubosomes to vesicles. The results contribute to the fundamental understanding of the self-assembly of pH-responsive and surfactant-like lipids. The presented experimental findings on the designed pHresponsive 2OHOA/GMO nano-self-assemblies could guide the development of advanced cancer nanomedicines for targeted delivery of chemotherapeutics.\n■ ASSOCIATED CONTENT *S Supporting Information The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.langmuir.9b00838.\nDetails on the critical packing parameter model, SAXS data analysis, and calculation of the pKa\napp from the ζpotential data (PDF)\n■ AUTHOR INFORMATION Corresponding Authors *E-mail: stefan.salentinig@unifr.ch. *E-mail: anan.yaghmur@sund.ku.dk."
    }, {
      "heading" : "ORCID",
      "text" : "Mark Gontsarik: 0000-0001-7613-5137 Anan Yaghmur: 0000-0003-1608-773X Stefan Salentinig: 0000-0002-7541-2734"
    }, {
      "heading" : "Author Contributions",
      "text" : "∥R.P. and M.G. contributed equally to this work."
    }, {
      "heading" : "Notes",
      "text" : "The authors declare no competing financial interest.\n■ ACKNOWLEDGMENTS Authors are grateful to Heinz Amenitsch and Jianing Li for technical support during synchrotron SAXS experiments and Tillmann Pape (Core Facility for Integrated Microscopy, University of Copenhagen) for technical assistance with cryo-\nTEM imaging. The authors acknowledge the Swiss National Science Foundation (Project 200021_169513 held by StS) for funding this research. Financial support to AY by the Danish Council for Independent Research, Technology and Production Sciences, reference 1335−00150b, is gratefully acknowledged. AY further acknowledges financial support from the Danish Natural Sciences Research Council (DanScatt) for SAXS experiments.\n■ ABBREVIATIONS 2-OHOA 2-hydroxyoleic acid GMO glycerol monooleate SAXS small-angle X-ray scattering cryo-TEM cryogenic-transmission electron microscopy H2 inverted type hexagonal phase PBS phosphate buffer saline MLVs multilamellar vesicles ULVs unilamellar vesicles\n■ REFERENCES (1) Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2018. CaCancer J. Clin. 2018, 68 (1), 7−30. (2) Wang, H.; Naghavi, M.; Allen, C.; Barber, R. M.; Carter, A.; Casey, D. C.; Charlson, F. J.; Chen, A. Z.; Coates, M. M.; Coggeshall, M.; et al. Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980−2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet 2016, 388, 1459−1544. (3) Fitzmaurice, C.; Allen, C.; Barber, R. M.; Barregard, L.; Bhutta, Z. A.; Brenner, H.; Dicker, D. J.; Chimed-Orchir, O.; Dandona, R.; Dandona, L.; et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017, 3 (4), 524−548. (4) Terry, A. R.; Plotkin, S. R. Chemotherapy: Present and Future. Otolaryngol. Clin. North Am. 2012, 45 (2), 471−486. (5) Sawyers, C. Targeted Cancer Therapy. Nature 2004, 432 (7015), 294−297. (6) Brannon-Peppas, L.; Blanchette, J. O. Nanoparticle and Targeted Systems for Cancer Therapy. Adv. Drug Delivery Rev. 2012, 64, 206− 212. (7) Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy. Nat. Nanotechnol. 2007, 2 (12), 751−760. (8) Bae, Y. H.; Park, K. Targeted Drug Delivery to Tumors: Myths, Reality and Possibility. J. Controlled Release 2011, 153 (3), 198−205. (9) Dai, L.; Liu, J.; Luo, Z.; Li, M.; Cai, K. Tumor Therapy: Targeted Drug Delivery Systems. J. Mater. Chem. B 2016, 4 (42), 6758−6772. (10) Bor, G.; Azmi, I. D. M.; Yaghmur, A. Nanomedicines for Cancer Therapy: Current Status, Challenges and Future Prospects. Ther. Delivery 2019, 10 (2), 113−132. (11) Tannock, I. F.; Rotin, D. Acid PH in Tumors and Its Potential for Therpeutic Exploitation. Cancer Res. 1989, 49 (16), 4373−4384. (12) Kato, Y.; Ozawa, S.; Miyamoto, C.; Maehata, Y.; Suzuki, A.; Maeda, T.; Baba, Y. Acidic Extracellular Microenvironment and Cancer. Cancer Cell Int. 2013, 13 (1), 1−8. (13) Negrini, R.; Fong, W.; Boyd, B. J.; Mezzenga, R. PHResponsive Lyotropic Liquid Crystals and Their Potential Therapeutic Role in Cancer Treatment. Chem. Commun. 2015, 51 (30), 6671−6674. (14) Chen, W.; Meng, F.; Cheng, R.; Zhong, Z. PH-Sensitive Degradable Polymersomes for Triggered Release of Anticancer Drugs: A Comparative Study with Micelles. J. Controlled Release 2010, 142 (1), 40−46.\nDOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\n7959\n(15) Sim, T.; Lim, C.; Hoang, N. H.; Oh, K. T. Recent Advance of PH-Sensitive Nanocarriers Targeting Solid Tumors. J. Pharm. Invest. 2017, 47 (5), 383−394. (16) Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review. J. Controlled Release 2000, 65 (1), 271−284. (17) Cammas, S.; Suzuki, K.; Sone, C.; Sakurai, Y.; Kataoka, K.; Okano, T. Thermo-Responsive Polymer Nanoparticles with a CoreShell Micelle Structure as Site-Specific Drug Carriers. J. Controlled Release 1997, 48 (2−3), 157−164. (18) Soga, O.; Van Nostrum, C. F.; Fens, M.; Rijcken, C. J. F.; Schiffelers, R. M.; Storm, G.; Hennink, W. E. Thermosensitive and Biodegradable Polymeric Micelles for Paclitaxel Delivery. J. Controlled Release 2005, 103 (2), 341−353. (19) Jang, E. J.; Choi, W. R.; Kim, S. Y.; Hong, S. S.; Rhee, I.; Lee, S. J.; Choi, S. W.; Choi, H. G.; Lim, S. J. 2-Hydroxyoleic Acid-Inserted Liposomes as a Multifunctional Carrier of Anticancer Drugs. Drug Delivery 2017, 24 (1), 1587−1597. (20) Escriba,́ P.; Busquets, X.; Inokuchi, J.; Balogh, G.; Török, Z.; Horvat́h, I.; Harwood, J. L.; Vígh, L. Membrane Lipid Therapy: Modulation of the Cell Membrane Composition and Structure as a Molecular Base for Drug Discovery and New Disease Treatment. Prog. Lipid Res. 2015, 59, 38−53. (21) Martin, M. L.; Barcelo-́Coblijn, G.; De Almeida, R. F. M.; Noguera-Salva,̀ M. A.; Tereś, S.; Higuera, M.; Liebisch, G.; Schmitz, G.; Busquets, X.; Escriba,́ P. V. The Role of Membrane Fatty Acid Remodeling in the Antitumor Mechanism of Action of 2- Hydroxyoleic Acid. Biochim. Biophys. Acta, Biomembr. 2013, 1828 (5), 1405−1413. (22) Teres, S.; Llado, V.; Higuera, M.; Barcelo-Coblijn, G.; Martin, M. L.; Noguera-Salva, M. A.; Marcilla-Etxenike, A.; Garcia-Verdugo, J. M.; Soriano-Navarro, M.; Saus, C.; et al. 2-Hydroxyoleate, a Nontoxic Membrane Binding Anticancer Drug, Induces Glioma Cell Differentiation and Autophagy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (22), 8489−8494. (23) Llado, V.; Gutierrez, A.; Martínez, J.; Casas, J.; Tereś, S.; Higuera, M.; Galmeś, A.; Saus, C.; Besalduch, J.; Busquets, X.; et al. Minerval Induces Apoptosis in Jurkat and Other Cancer Cells. J. Cell. Mol. Med. 2009, 14 (3), 659−670. (24) Martinez, J.; Vogler, O.; Casas, J.; Barcelo, F.; Alemany, R.; Prades, J.; Nagy, T.; Baamonde, C.; Kasprzyk, P. G.; Teres, S.; et al. Membrane Structure Modulation, Protein Kinase c Activation, and Anticancer Activity of Minerval. Mol. Pharmacol. 2004, 67 (2), 531− 540. (25) Llado, V.; Teres, S.; Higuera, M.; Alvarez, R.; Noguera-Salva, M. A.; Halver, J. E.; Escriba, P. V.; Busquets, X. Pivotal Role of Dihydrofolate Reductase Knockdown in the Anticancer Activity of 2- Hydroxyoleic Acid. Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (33), 13754−13758. (26) Marcilla-Etxenike, A.; Martın, M. L.; Noguera-Salva, M. A.; Garcı, M.; Anto, M.; Busquets, X.; Soriano-navarro, M.; Dey, I.; Escriba, P. V. 2-Hydroxyoleic Acid Induces ER Stress and Autophagy in Various Human Glioma Cell Lines. PLoS One 2012, 7 (10), e48235. (27) Torgersen, M. L.; Klokk, T. I.; Kavaliauskiene, S.; Klose, C.; Simons, K.; Skotland, T.; Sandvig, K. The Anti-Tumor Drug 2- Hydroxyoleic Acid (Minerval) Stimulates Signaling and Retrograde Transport. Oncotarget 2016, 7 (52), 86871−86888. (28) Chen, Y.; Ma, P.; Gui, S. Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems. BioMed Res. Int. 2014, 2014, 1−12. (29) Gontsarik, M.; Buhmann, M. T.; Yaghmur, A.; Ren, Q.; Maniura-weber, K.; Salentinig, S. Antimicrobial Peptide-Driven Colloidal Transformations in Liquid- Crystalline Nanocarriers. J. Phys. Chem. Lett. 2016, 7 (17), 3482−3486. (30) Milak, S.; Zimmer, A. Glycerol Monooleate Liquid Crystalline Phases Used in Drug Delivery Systems. Int. J. Pharm. 2015, 478 (2), 569−587.\n(31) Nazaruk, E.; Majkowska-Pilip, A.; Bilewicz, R. Lipidic CubicPhase Nanoparticles-Cubosomes for Efficient Drug Delivery to Cancer Cells. ChemPlusChem 2017, 82 (4), 570−575. (32) Larsson, K. Cubic Lipid-Water Phases: Structures and Biomembrane Aspects. J. Phys. Chem. 1989, 93 (21), 7304−7314. (33) Salentinig, S.; Tangso, K. J.; Hawley, A.; Boyd, B. J. PH-Driven Colloidal Transformations Based on the Vasoactive Drug Nicergoline. Langmuir 2014, 30 (49), 14776−14781. (34) Azmi, I. D. M.; Moghimi, S. M.; Yaghmur, A. Cubosomes and Hexosomes as Versatile Platforms for Drug Delivery. Ther. Delivery 2015, 6 (12), 1347−1364. (35) Yaghmur, A.; Glatter, O. Characterization and Potential Applications of Nanostructured Aqueous Dispersions. Adv. Colloid Interface Sci. 2009, 147−148, 333−342. (36) Hyde, S. T. Bicontinuous Structures in Lyotropic Liquid Crystals and Crystalline Hyperbolic Surfaces. Curr. Opin. Solid State Mater. Sci. 1996, 1 (5), 653−662. (37) Seddon, J. M. Structure of the Inverted Hexagonal (HII) Phase, and Non-Lamellar Phase Transitions of Lipids. Biochim. Biophys. Acta, Rev. Biomembr. 1990, 1031 (1), 1−69. (38) Guo, C.; Wang, J.; Cao, F.; Lee, R. J.; Zhai, G. Lyotropic Liquid Crystal Systems in Drug Delivery. Drug Discovery Today 2010, 15 (23−24), 1032−1040. (39) Shao, X.; Bor, G.; Al-Hosayni, S.; Salentinig, S.; Yaghmur, A. Structural Characterization of Self-Assemblies of New Omega-3 Lipids: Docosahexaenoic Acid and Docosapentaenoic Acid Monoglycerides. Phys. Chem. Chem. Phys. 2018, 20, 23928−23941. (40) Yaghmur, A.; Al-hosayni, S.; Amenitsch, H.; Salentinig, S. Structural Investigation of Bulk and Dispersed Inverse Lyotropic Hexagonal Liquid Crystalline Phases of Eicosapentaenoic Acid Monoglyceride. Langmuir 2017, 33 (49), 14045−14057. (41) Luzzati, V. The Structure of the Liquid-Crystalline Phases of Lipid-Water Systems. J. Cell Biol. 1962, 12 (2), 207−219. (42) Barauskas, J.; Johnsson, M.; Tiberg, F. Self-Assembled Lipid Superstructures : Beyond Vesicles and Liposomes. Nano Lett. 2005, 5 (8), 1615−1619. (43) Kaasgaard, T.; Drummond, C. J. Ordered 2-D and 3-D Nanostructured Amphiphile Self-Assembly Materials Stable in Excess Solvent. Phys. Chem. Chem. Phys. 2006, 8 (43), 4957−4975. (44) Fong, C.; Le, T.; Drummond, C. J. Lyotropic Liquid Crystal Engineering−ordered Nanostructured Small Molecule Amphiphile Self-Assembly Materials by Design. Chem. Soc. Rev. 2012, 41 (3), 1297−1322. (45) Tiberg, F.; Johnsson, M. Drug Delivery Applications of NonLamellar Liquid Crystalline Phases and Nanoparticles. J. Drug Delivery Sci. Technol. 2011, 21 (1), 101−109. (46) Drummond, C. J.; Fong, C. Surfactant Self-Assembly Objects as Novel Drug Delivery Vehicles. Curr. Opin. Colloid Interface Sci. 1999, 4 (6), 449−456. (47) Malmsten, M. Phase Transformations in Self-Assembly Systems for Drug Delivery Applications. J. Dispersion Sci. Technol. 2007, 28 (1), 63−72. (48) Yaghmur, A.; Rappolt, M.; Larsen, S. W. In Situ Forming Drug Delivery Systems Based on Lyotropic Liquid Crystalline Phases : Structural Characterization and Release Properties. J. Drug Delivery Sci. Technol. 2013, 23 (4), 325−332. (49) Negrini, R.; Mezzenga, R. PH-Responsive Lyotropic Liquid Crystals for Controlled Drug Delivery. Langmuir 2011, 27 (9), 5296− 5303. (50) Gontsarik, M.; Mohammadtaheri, M.; Yaghmur, A.; Salentinig, S. PH-Triggered Nanostructural Transformations in Antimicrobial Peptide/Oleic Acid Self-Assemblies. Biomater. Sci. 2018, 6 (4), 803− 812. (51) Fong, W.; Hanley, T.; Boyd, B. J. Stimuli Responsive Liquid Crystals Provide ‘on-Demand’ Drug Delivery in Vitro and in Vivo. J. Controlled Release 2009, 135 (3), 218−226. (52) Salentinig, S.; Sagalowicz, L.; Glatter, O. Self-Assembled Structures and PKa Value of Oleic Acid in Systems of Biological Relevance. Langmuir 2010, 26 (14), 11670−11679.\nDOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\n7960\n(53) Agasti, S. S.; Chompoosor, A.; You, C.; Ghosh, P.; Kim, C. K.; Rotello, V. M. Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles to Regulate Drug Release, Minimizing Side Effects and Improving. J. Am. Chem. Soc. 2009, 131, 5728−5729. (54) Bayer, C. L.; Peppas, N. A. Advances in Recognitive, Conductive and Responsive Delivery Systems. J. Controlled Release 2008, 132 (3), 216−221. (55) Gao, Z. G.; Fain, H. D.; Rapoport, N. Controlled and Targeted Tumor Chemotherapy by Micellar-Encapsulated Drug and Ultrasound. J. Controlled Release 2005, 102 (1), 203−222. (56) Barriga, H. M. G.; Holme, M. N.; Stevens, M. M. Cubosomes : The Next Generation of Smart Lipid Nanoparticles ? Angew. Chem., Int. Ed. 2019, 58, 2958−2978. (57) Otte, A.; Soh, B.; Yoon, G.; Park, K. Liquid Crystalline Drug Delivery Vehicles for Oral and IV/Subcutaneous Administration of Poorly Soluble (and Soluble) Drugs. Int. J. Pharm. 2018, 539, 175− 183. (58) Nasr, M.; Ghorab, M. K.; Abdelazem, A. In Vitro and in Vivo Evaluation of Cubosomes Containing 5-Fluorouracil for Liver Targeting. Acta Pharm. Sin. B 2015, 5 (1), 79−88. (59) Jain, V.; Swarnakar, N. K.; Mishra, P. R.; Verma, A.; Kaul, A.; Mishra, A. K.; Jain, N. K. Paclitaxel Loaded PEGylated Gleceryl Monooleate Based Nanoparticulate Carriers in Chemotherapy. Biomaterials 2012, 33 (29), 7206−7220. (60) Hammersley, A. P.; Svensson, S. O.; Hanfland, M.; Fitch, A. N.; Hausermann, D. Two-Dimensional Detector Software: From Real Detector to Idealised Image or Two-Theta Scan. High Pressure Res. 1996, 14, 235−248. (61) Smoluchowski, M. Handbuch Der Electrizita ̈t Und Des Magnetismus (Graetz). Leipzig, Ger. Barth 1921, 2, 366. (62) Gustafsson, J.; Ljusberg-wahren, H.; Almgren, M.; Larsson, K. Submicron Particles of Reversed Lipid Phases in Water Stabilized by a Nonionic Amphiphilic Polymer. Langmuir 1997, 13 (26), 6964− 6971. (63) Landh, T. Phase Behavior in the System Pine Needle Oil Monoglycerides-Poloxamer 407-Water at 20.Degree. J. Phys. Chem. 1994, 98, 8453−8467. (64) Barcelo,́ F.; Prades, J.; Funari, S. S.; Frau, J.; Alemany, R.; Escriba,́ P. V. The Hypotensive Drug 2-Hydroxyoleic Acid Modifies the Structural Properties of Model Membranes of Model Membranes. Mol. Membr. Biol. 2004, 21, 261−268. (65) Hyde, S. T. Microstructure of Bicontinuous Surfactant Aggregates. J. Phys. Chem. 1989, 93, 1458−1464. (66) Chung, H.; Caffrey, M. The Neutral Area Surface of the Cubic Mesophase: Location and Properties. Biophys. J. 1994, 66, 377−381. (67) Yaghmur, A.; Laggner, P.; Sartori, B.; Rappolt, M. Calcium Triggered Lα-H2 Phase Transition Monitored by Combined Rapid Mixing and Time-Resolved Synchrotron SAXS. PLoS One 2008, 3 (4), e2072. (68) Murgia, S.; Caboi, F.; Monduzzi, M.; Ljusberg-Wahren, H.; Nylander, T. Acyl Migration and Hydrolysis in Monoolein-Based Systems. Springer Berlin Heidelberg 2002, 120, 41−46. (69) Suga, K.; Kondo, D.; Otsuka, Y.; Okamoto, Y.; Umakoshi, H. Characterization of Aqueous Oleic Acid/Oleate Dispersions by Fluorescent Probes and Raman Spectroscopy. Langmuir 2016, 32, 7606−7612. (70) Gontsarik, M.; Yaghmur, A.; Ren, Q.; Maniura-Weber, K.; Salentinig, S. From Structure to Function: PH-Switchable Antimicrobial Nano-Self-Assemblies. ACS Appl. Mater. Interfaces 2019, 11, 2821−2829. (71) Salentinig, S.; Phan, S.; Darwish, T. A.; Kirby, N.; Boyd, B. J.; Gilbert, E. P. PH-Responsive Micelles Based on Caprylic Acid. Langmuir 2014, 30, 7296−7303. (72) Cistola, D. P.; Hamilton, J. A.; Jackson, D.; Small, D. M. Ionization and Phase Behavior of Fatty Acids in Water: Application of the Gibbs Phase Rule. Biochemistry 1988, 27 (6), 1881−1888. (73) Nilsson, C.; Edwards, K.; Eriksson, J.; Larsen, S. W.; Østergaard, J.; Larsen, C.; Urtti, A.; Yaghmur, A. Characterization of Oil-Free and Oil-Loaded Liquid-Crystalline Particles Stabilized by\nNegatively Charged Stabilizer Citrem. Langmuir 2012, 28 (32), 11755−11766. (74) Yaghmur, A.; De Campo, L.; Sagalowicz, L.; Leser, M. E.; Glatter, O. Emulsified Microemulsions and Oil-Containing Liquid Crystalline Phases. Langmuir 2005, 21 (2), 569−577. (75) Yaghmur, A.; De Campo, L.; Salentinig, S.; Sagalowicz, L.; Leser, M. E.; Glatter, O. Oil-Loaded Monolinolein-Based Particles with Confined Inverse Discontinuous Cubic Structure (Fd3m). Langmuir 2006, 22 (2), 517−521. (76) Yaghmur, A.; Sartori, B.; Rappolt, M. Self-Assembled Nanostructures of Fully Hydrated Monoelaidin− Elaidic Acid and Monoelaidin-Oleic Acid Systems. Langmuir 2012, 28, 10105−10119. (77) Amar-yuli, I.; Garti, N. Transitions Induced by Solubilized Fat into Reverse Hexagonal Mesophases. Colloids Surf., B 2005, 43, 72− 82. (78) Prades, J.; Funari, S. S.; Escriba,́ P. V.; Barcelo,́ F. Effects of Unsaturated Fatty Acids and Triacylglycerols on Phosphatidylethanolamine Membrane Structure. J. Lipid Res. 2003, 44, 1720−1727.\nDOI: 10.1021/acs.langmuir.9b00838 Langmuir 2019, 35, 7954−7961\n7961"
    } ],
    "references" : [ {
      "title" : "Chemotherapy: Present and Future",
      "author" : [ "A.R. Terry", "S.R. Plotkin" ],
      "venue" : "Otolaryngol. Clin. North Am. 2012,",
      "citeRegEx" : "Terry and Plotkin,? \\Q2012\\E",
      "shortCiteRegEx" : "Terry and Plotkin",
      "year" : 2012
    }, {
      "title" : "Targeted Cancer Therapy",
      "author" : [ "C. Sawyers" ],
      "venue" : "Nature 2004,",
      "citeRegEx" : "Sawyers,? \\Q2004\\E",
      "shortCiteRegEx" : "Sawyers",
      "year" : 2004
    }, {
      "title" : "Nanoparticle and Targeted Systems for Cancer Therapy",
      "author" : [ "L. Brannon-Peppas", "J.O. Blanchette" ],
      "venue" : "Adv. Drug Delivery Rev. 2012,",
      "citeRegEx" : "Brannon.Peppas and Blanchette,? \\Q2012\\E",
      "shortCiteRegEx" : "Brannon.Peppas and Blanchette",
      "year" : 2012
    }, {
      "title" : "Nanocarriers as an Emerging Platform for Cancer Therapy",
      "author" : [ "R. Langer" ],
      "venue" : "Nat. Nanotechnol. 2007,",
      "citeRegEx" : "Langer,? \\Q2007\\E",
      "shortCiteRegEx" : "Langer",
      "year" : 2007
    }, {
      "title" : "Targeted Drug Delivery to Tumors: Myths, Reality and Possibility",
      "author" : [ "Y.H. Bae", "K. Park" ],
      "venue" : "J. Controlled Release 2011,",
      "citeRegEx" : "Bae and Park,? \\Q2011\\E",
      "shortCiteRegEx" : "Bae and Park",
      "year" : 2011
    }, {
      "title" : "Acid PH in Tumors and Its Potential for Therpeutic Exploitation",
      "author" : [ "I.F. Tannock", "D. Rotin" ],
      "venue" : "Cancer Res. 1989,",
      "citeRegEx" : "Tannock and Rotin,? \\Q1989\\E",
      "shortCiteRegEx" : "Tannock and Rotin",
      "year" : 1989
    }, {
      "title" : "Acidic Extracellular Microenvironment and Cancer",
      "author" : [ "T. Maeda", "Y. Baba" ],
      "venue" : "Cancer Cell Int. 2013,",
      "citeRegEx" : "Maeda and Baba,? \\Q2013\\E",
      "shortCiteRegEx" : "Maeda and Baba",
      "year" : 2013
    }, {
      "title" : "Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems",
      "author" : [ "Y. Chen", "P. Ma", "S. Gui" ],
      "venue" : "BioMed Res. Int",
      "citeRegEx" : "Chen et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Chen et al\\.",
      "year" : 2014
    }, {
      "title" : "Cubic Lipid-Water Phases: Structures and Biomembrane Aspects",
      "author" : [ "K. Larsson" ],
      "venue" : "J. Phys. Chem. 1989,",
      "citeRegEx" : "Larsson,? \\Q1989\\E",
      "shortCiteRegEx" : "Larsson",
      "year" : 1989
    }, {
      "title" : "The Structure of the Liquid-Crystalline Phases of Lipid-Water Systems",
      "author" : [ "V. Luzzati" ],
      "venue" : "J. Cell Biol. 1962,",
      "citeRegEx" : "Luzzati,? \\Q1962\\E",
      "shortCiteRegEx" : "Luzzati",
      "year" : 1962
    }, {
      "title" : "PH-Responsive Lyotropic Liquid Crystals for Controlled Drug Delivery",
      "author" : [ "R. Negrini", "R. Mezzenga" ],
      "venue" : "Langmuir 2011,",
      "citeRegEx" : "Negrini and Mezzenga,? \\Q2011\\E",
      "shortCiteRegEx" : "Negrini and Mezzenga",
      "year" : 2011
    }, {
      "title" : "Nanostructural Transformations in Antimicrobial Peptide/Oleic Acid Self-Assemblies",
      "author" : [ "S. PH-Triggered" ],
      "venue" : "Biomater. Sci. 2018,",
      "citeRegEx" : "PH.Triggered,? \\Q2018\\E",
      "shortCiteRegEx" : "PH.Triggered",
      "year" : 2018
    }, {
      "title" : "Microstructure of Bicontinuous Surfactant Aggregates",
      "author" : [ "S.T. Hyde" ],
      "venue" : "J. Phys. Chem",
      "citeRegEx" : "Hyde,? \\Q1989\\E",
      "shortCiteRegEx" : "Hyde",
      "year" : 1989
    }, {
      "title" : "The Neutral Area Surface of the Cubic Mesophase: Location and Properties",
      "author" : [ "H. Chung", "M. Caffrey" ],
      "venue" : "Biophys. J. 1994,",
      "citeRegEx" : "Chung and Caffrey,? \\Q1994\\E",
      "shortCiteRegEx" : "Chung and Caffrey",
      "year" : 1994
    }, {
      "title" : "Acyl Migration and Hydrolysis in Monoolein-Based Systems",
      "author" : [ "T. Nylander" ],
      "venue" : null,
      "citeRegEx" : "Nylander,? \\Q2002\\E",
      "shortCiteRegEx" : "Nylander",
      "year" : 2002
    }, {
      "title" : "PH-Responsive Micelles Based on Caprylic Acid",
      "author" : [ "E.P. Gilbert" ],
      "venue" : "Langmuir 2014,",
      "citeRegEx" : "Gilbert,? \\Q2014\\E",
      "shortCiteRegEx" : "Gilbert",
      "year" : 2014
    }, {
      "title" : "Emulsified Microemulsions and Oil-Containing Liquid Crystalline Phases",
      "author" : [ "O. Glatter" ],
      "venue" : "Langmuir 2005,",
      "citeRegEx" : "Glatter,? \\Q2005\\E",
      "shortCiteRegEx" : "Glatter",
      "year" : 2005
    }, {
      "title" : "Self-Assembled Nanostructures of Fully Hydrated Monoelaidin− Elaidic Acid and Monoelaidin-Oleic Acid Systems",
      "author" : [ "A. Yaghmur", "B. Sartori", "M. Rappolt" ],
      "venue" : "Langmuir 2012,",
      "citeRegEx" : "Yaghmur et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Yaghmur et al\\.",
      "year" : 2012
    }, {
      "title" : "Transitions Induced by Solubilized Fat into Reverse Hexagonal Mesophases",
      "author" : [ "I. Amar-yuli", "N. Garti" ],
      "venue" : "Colloids Surf., B 2005,",
      "citeRegEx" : "Amar.yuli and Garti,? \\Q2005\\E",
      "shortCiteRegEx" : "Amar.yuli and Garti",
      "year" : 2005
    } ],
    "referenceMentions" : [ ],
    "year" : 2019,
    "abstractText" : "pH-responsive lipid nanocarriers have the potential to selectively target the acidic extracellular pH environment of cancer tissues and may further improve the efficacy of chemotherapeutics by minimizing their toxic sideeffects. Here, we present the design and characterization of pH-sensitive nano-self-assemblies of the poorly water-soluble anticancer drug 2-hydroxyoleic acid (2OHOA) with glycerol monooleate (GMO). pH-triggered nanostructural transformations from 2OHOA/GMO nanoparticles with an internal inverse hexagonal structure (hexosomes) at pH around 2.0−3.0, via nanocarriers with an internal inverse bicontinuous cubic structure (cubosomes) at pH 2.0−4.5, to vesicles at pH 4.5−7.4 were observed with synchrotron smallangle X-ray scattering, and cryogenic transmission electron microscopy. ζ-potential measurements highlight that the pH-driven deprotonation of the carboxylic group of 2OHOA, and the resulting charge-repulsions at the lipid−water interface account for these nanostructural alterations. The study provides detailed insight into the pH-dependent self-assembly of 2OHOA with GMO in excess buffer at physiologically relevant pH values, and discusses the effects of pH alterations on modulating their nanostructure. The results may guide the further development of pH-responsive anticancer nanocarriers for the targeted delivery of chemotherapeutics to the local microenvironment of tumor cells.",
    "creator" : "PTC Arbortext Advanced Print Publisher 11.1.4300/W Library-x64"
  }
}